Literature DB >> 28627462

Clinical and Pathological Staging Validation in the Eighth Edition of the TNM Classification for Lung Cancer: Correlation between Solid Size on Thin-Section Computed Tomography and Invasive Size in Pathological Findings in the New T Classification.

Keiju Aokage1, Tomohiro Miyoshi2, Genichiro Ishii3, Masahiro Kusumoto4, Shogo Nomura5, Shinya Katsumata2, Keigo Sekihara2, Tomoyuki Hishida2, Masahiro Tsuboi2.   

Abstract

INTRODUCTION: The aim of this study was to validate the new eighth edition of the TNM classification and to elucidate whether radiological solid size corresponds to pathological invasive size incorporated in this T factor.
METHODS: We analyzed the data on 1792 patients who underwent complete resection from 2003 to 2011 at the National Cancer Center Hospital East, Japan. We reevaluated preoperative thin-section computed tomography (TSCT) to determine solid size and pathological invasive size using the fourth edition of the WHO classification and reclassified them according to the new TNM classification. The discriminative power of survival curves by the seventh edition was compared with that by the eighth edition by using concordance probability estimates and Akaike's information criteria calculated using a univariable Cox regression model. Pearson's correlation coefficient was calculated to elucidate the correlation between radiological solid size using TSCT and pathological invasive size.
RESULTS: The overall survival curves in the eighth edition were well distinct at each clinical and pathological stage. The 5-year survival rates of patients with clinical and pathological stage 0 newly defined were both 100%. The concordance probability estimate and Akaike's information criterion values of the eighth edition were higher than those of the seventh edition in discriminatory power for overall survival. Solid size on TSCT scan and pathological invasive size showed a positive linear relationship, and Pearson's correlation coefficient was calculated as 0.83, which indicated strong correlation.
CONCLUSIONS: This TNM classification will be feasible regarding patient survival, and radiological solid size correlates significantly with pathological invasive size as a new T factor.
Copyright © 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Invasive size; Lung cancer; NSCLC; New TNM classification; Solid size

Mesh:

Year:  2017        PMID: 28627462     DOI: 10.1016/j.jtho.2017.06.003

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  15 in total

1.  Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma.

Authors:  Koji Kameda; Takashi Eguchi; Shaohua Lu; Yang Qu; Kay See Tan; Kyuichi Kadota; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2018-09-07       Impact factor: 15.609

2.  Verification of T descriptor with consolidation size for sub-centimeter non-small cell lung cancer.

Authors:  Masaki Goto; Koji Kawaguchi; Takayuki Fukui; Shota Nakamura; Shuhei Hakiri; Naoki Ozeki; Shunsuke Mori; Kumiko Hashimoto; Toshinari Ito; Kohei Yokoi
Journal:  Surg Today       Date:  2019-05-22       Impact factor: 2.549

3.  Ground glass opacities of the lung before, during and post COVID-19 pandemic.

Authors:  Marcello Migliore
Journal:  Ann Transl Med       Date:  2021-07

4.  Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules.

Authors:  Shingo Iwano; Hiroyasu Umakoshi; Shinichiro Kamiya; Kohei Yokoi; Koji Kawaguchi; Takayuki Fukui; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2019-06-07       Impact factor: 3.909

5.  Distinct clinicopathologic factors and prognosis based on the presence of ground-glass opacity components in patients with resected stage I non-small cell lung cancer.

Authors:  Chengdi Wang; Yuxuan Wu; Jingwei Li; Pengwei Ren; Ya Gou; Jun Shao; Yaojie Zhou; Xue Xiao; Paierhati Tuersun; Dan Liu; Li Zhang; Weimin Li
Journal:  Ann Transl Med       Date:  2020-09

6.  Identification of LINC02310 as an enhancer in lung adenocarcinoma and investigation of its regulatory network via comprehensive analyses.

Authors:  Wenyuan Zhao; Jun Wang; Qingxi Luo; Wei Peng; Bin Li; Lei Wang; Chunfang Zhang; Chaojun Duan
Journal:  BMC Med Genomics       Date:  2020-12-11       Impact factor: 3.063

7.  Predictive factors of recurrence after resection of subsolid clinical stage IA lung adenocarcinoma.

Authors:  Dong Jin Im; Sang Min Lee; Kyunghwa Han; Chul Hwan Park; Ji Won Lee; Sung Ho Hwang; Jae Seung Seo; Woocheol Kwon; Kye Ho Lee; Jin Hur
Journal:  Thorac Cancer       Date:  2021-02-07       Impact factor: 3.500

8.  Comparison of PD-L1 Expression Status between Pure-Solid Versus Part-Solid Lung Adenocarcinomas.

Authors:  Kenichi Suda; Masaki Shimoji; Shigeki Shimizu; Katsuaki Sato; Masato Chiba; Kenji Tomizawa; Toshiki Takemoto; Junichi Soh; Tetsuya Mitsudomi
Journal:  Biomolecules       Date:  2019-09-07

9.  8th Edition Tumor, Node, and Metastasis T-Stage Prognosis Discrepancies: Solid Component Diameter Predicts Prognosis Better than Invasive Component Diameter.

Authors:  Kazuhito Funai; Akikazu Kawase; Kiyomichi Mizuno; Sin Koyama; Norihiko Shiiya
Journal:  Cancers (Basel)       Date:  2020-06-15       Impact factor: 6.639

10.  Clinical significance of part-solid lung cancer in the eighth edition TNM staging system.

Authors:  Tatsuro Okamoto; Michiyo Miyawaki; Gouji Toyokawa; Takashi Karashima; Miyuki Abe; Yohei Takumi; Takafumi Hashimoto; Atsuhi Osoegawa; Tetsuzo Tagawa; Hideya Takeuchi; Mototsugu Shimokawa; Kenji Sugio
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.